ChemDiv

ChemDiv, established in 1995, is a prominent contract research organization (CRO) based in San Diego, California. The company specializes in providing comprehensive development solutions tailored for the pharmaceutical and biotechnology sectors. Its core mission revolves around accelerating drug discovery and development pipelines through innovative chemistry and R&D services. ChemDiv offers a wide array of services, including discovery chemistry, medicinal chemistry, and the design and synthesis of novel small molecules and building blocks. They are recognized for their expertise in integrated drug discovery, aiming to deliver high-quality candidates for therapeutic development programs.

Operating with a dedicated team of 500-1,000 employees, ChemDiv maintains a focused operational footprint with one primary location. This concentrated approach allows for efficient project management and close collaboration with clients. The company's expertise extends to custom synthesis and the provision of diverse chemical libraries essential for screening and lead optimization. Clients rely on ChemDiv for its agile project teams and its ability to manage complex R&D projects from concept to candidate selection. For insights into the people driving these advancements, one can Meet ChemDiv's team.

Financially, ChemDiv reported revenue of $32.9M. The company has secured funding, including a $150,000 debt round in May 2020. Its services are critical for companies seeking to advance their pipelines in areas such as regenerative medicine and novel therapies. ChemDiv competes in a dynamic market with numerous players offering specialized CRO services. For a detailed overview of its financial performance and metrics, interested parties can Explore financial highlights. The company's strategic focus on design-driven discoveryView more...